Hypertrophic Cardiomyopathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
In summary, MLP-deficient hESC-CMs recapitulate the pathogenesis of HCM and its progression toward HF, providing an important human model for investigation of CSRP3/MLP-associated disease pathogenesis.
|
31406109 |
2019 |
Hypertrophic Cardiomyopathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
By combining meta-analysis results and identification of two unrelated HCM patients with homozygous CSRP3 truncating variants, we suggest that the association of CSRP3 as a validated HCM-causing gene require additional studies and those CSRP3 variants could result in HCM with an autosomal recessive inheritance rather than with an autosomal dominant transmission as usually reported on HCM (OMIM 612124).
|
30012424 |
2018 |
Hypertrophic Cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Protein depletion was also observed in cellular studies for two further HCM-causing CSRP3 mutations (L44P and S54R/E55G).
|
30048712 |
2018 |
Hypertrophic Cardiomyopathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
CSRP3-W4R has previously been linked to dilated and hypertrophic cardiomyopathy, but was also found in healthy subjects.
|
25145518 |
2014 |
Hypertrophic Cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Our functional data from both in vitro and in vivo analyses suggest that at least one of MLP's mutated forms seems to be destabilized in the heart of HCM patients harbouring a CSRP3 missense mutation.
|
18505755 |
2008 |
Hypertrophic Cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
LHGDN |
Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy.
|
18505755 |
2008 |
Hypertrophic Cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
DNA was obtained from 389 patients with HCM (215 male, left ventricular wall thickness of 21.6+/-6 mm) and analyzed for mutations involving all translated exons of CSRP3 and TCAP and targeted HCM-associated exons (2, 3, 4, and 14) of TTN using polymerase chain reaction (PCR), denaturing high performance liquid chromatography (DHPLC), and direct DNA sequencing.
|
16352453 |
2006 |
Hypertrophic Cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Thirteen of the 239 patients (5.4%) had one of 13 distinct HCM-associated Z-disc mutations involving residues highly conserved across species and absent in 600 reference alleles: LDB3 (6), ACTN2 (3), TCAP (1), CSRP3 (1), and VCL (2).
|
17097056 |
2006 |
Hypertrophic Cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Based upon these data, and the recent descriptions of mutations in MLP in patients with DCM or hypertrophic cardiomyopathy, we screened patients for mutations in the MLP and alpha-actinin-2 genes.
|
14567970 |
2004 |
Hypertrophic Cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The molecular basis for HCM-causing mutations in the MLP gene might therefore be an alteration in the equilibrium of interactions of the ternary complex MLP-N-RAP-alpha-actinin.
|
15205937 |
2004 |
Hypertrophic Cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Recent genetic investigations have revealed that mutations of genes encoding Z-disc components, including titin and muscle LIM protein (MLP), are the primary cause of both HCM and DCM.
|
15582318 |
2004 |
Hypertrophic Cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
LHGDN |
MLP is therefore a candidate gene for heritable forms of hypertrophic cardiomyopathy (HCM) and DCM in humans.
|
12642359 |
2003 |
Hypertrophic Cardiomyopathy
|
0.100 |
Biomarker
|
disease |
BEFREE |
MLP is therefore a candidate gene for heritable forms of hypertrophic cardiomyopathy (HCM) and DCM in humans.
|
12642359 |
2003 |